CTNM
Price
$5.77
Change
+$0.07 (+1.23%)
Updated
Jul 25 closing price
Capitalization
149.28M
24 days until earnings call
RGNX
Price
$8.96
Change
-$0.17 (-1.86%)
Updated
Jul 25 closing price
Capitalization
451.48M
4 days until earnings call
Interact to see
Advertisement

CTNM vs RGNX

Header iconCTNM vs RGNX Comparison
Open Charts CTNM vs RGNXBanner chart's image
Contineum Therapeutics
Price$5.77
Change+$0.07 (+1.23%)
Volume$164.78K
Capitalization149.28M
REGENXBIO
Price$8.96
Change-$0.17 (-1.86%)
Volume$467.43K
Capitalization451.48M
CTNM vs RGNX Comparison Chart in %
Loading...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTNM vs. RGNX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CTNM: $5.77 vs. RGNX: $8.96)
Brand notoriety: CTNM and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 66% vs. RGNX: 54%
Market capitalization -- CTNM: $149.28M vs. RGNX: $451.48M
CTNM [@Biotechnology] is valued at $149.28M. RGNX’s [@Biotechnology] market capitalization is $451.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, CTNM is a better buy in the long-term than RGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 6 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • CTNM’s TA Score: 6 bullish, 4 bearish.
  • RGNX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CTNM is a better buy in the short-term than RGNX.

Price Growth

CTNM (@Biotechnology) experienced а +32.64% price change this week, while RGNX (@Biotechnology) price change was +9.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CTNM is expected to report earnings on Aug 19, 2025.

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($451M) has a higher market cap than CTNM($149M). RGNX YTD gains are higher at: 15.912 vs. CTNM (-60.614). CTNM has higher annual earnings (EBITDA): -50.16M vs. RGNX (-122.44M). RGNX has more cash in the bank: 268M vs. CTNM (191M). CTNM has less debt than RGNX: CTNM (6M) vs RGNX (79.8M). RGNX has higher revenues than CTNM: RGNX (157M) vs CTNM (0).
CTNMRGNXCTNM / RGNX
Capitalization149M451M33%
EBITDA-50.16M-122.44M41%
Gain YTD-60.61415.912-381%
P/E Ratio26.40N/A-
Revenue0157M-
Total Cash191M268M71%
Total Debt6M79.8M8%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
23
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTNMRGNX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGREX9.13N/A
N/A
Invesco Global Real Estate A
SUWCX32.91N/A
N/A
DWS Core Equity C
NBMIX48.85N/A
N/A
Neuberger Berman Small Cap Growth Inv
VMFGX463.74N/A
N/A
Vanguard S&P Mid-Cap 400 Growth Idx I
TPCFF0.52N/A
N/A
Titan Logix Corp.

CTNM and

Correlation & Price change

A.I.dvisor tells us that CTNM and CCCC have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTNM and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+1.23%
CCCC - CTNM
33%
Poorly correlated
-1.31%
RGNX - CTNM
32%
Poorly correlated
-1.86%
SLN - CTNM
31%
Poorly correlated
+0.96%
ARMP - CTNM
31%
Poorly correlated
-3.82%
XNCR - CTNM
31%
Poorly correlated
N/A
More